
Updates on MS Treatments and Exercise
Foralumab shows early positive results for SPMS, Ocrevus may work better than certain oral treatments, Kesimpta also beat pills, and combining cardio and aerobic exercise can help MS patients.
All articles tagged with #foralumab

Foralumab shows early positive results for SPMS, Ocrevus may work better than certain oral treatments, Kesimpta also beat pills, and combining cardio and aerobic exercise can help MS patients.

Orelabrutinib, a Bruton’s tyrosine kinase inhibitor, has shown promising results in reducing brain lesions in a Phase 2 trial for relapsing-remitting multiple sclerosis. A Phase 2 clinical trial for foralumab, an antibody-based nasal spray, is set to launch later this year for people with nonactive secondary progressive MS. Research suggests that adhering to high-quality diets such as McDougall, paleo, Swank, and Overcoming MS may help ease depression in MS patients. A small study in Iran suggests that drinking coffee and tea may protect against MS, but the self-reporting survey used in the study has limitations.